Texas Instruments Incorporated (TXN) has caught the attention of analysts once again as Tom O’Malley from Barclays initiated ...
Texas Instruments Incorporated (TXN) has recently captured investor attention with a bullish rating upgrade from Vivek Arya ...
W. R. Berkley Corporation (WRB) recently garnered a “Market Perform” rating from BMO Capital’s analyst, Michael Zaremski, a ...
GitLab Inc. (GTLB) has recently attracted attention from investors as it received a Neutral rating upgrade from Koji Ikeda of Bank of America Securities o. This shift comes amid a turbulent market ...
Barclays analyst Tom O’Malley assigned Penguin Solutions, Inc. (PENG) an Equal-Weight rating, with a price target set at $27.58. This shift comes as investors recalibrate expectations amidst ...
Biogen Inc. (NASDAQ: BIIB) has recently been upgraded to a “Buy” rating by UBS analyst Michael Yee, with a new price target set at $225, signaling strong upside potential from the current trading ...
In a recent note from Joshua Spector at UBS, Xylem Inc. (XYL) received a Neutral rating, indicating a stable outlook for the water technology and equipment company. This assessment comes with a price ...
Arrowhead Pharmaceuticals, Inc. (ARWR): Morgan Stanley Upgrades to Overweight with $100 Price Target
Arrowhead Pharmaceuticals, Inc. (ARWR) recently caught the attention of investors as Morgan Stanley’s analyst Michael Ulz upgraded the stock to an Overweight rating on April 21, 2026. This upgrade ...
Our proprietary market analysis suggests predictions for OFS Capital 's price over the next three months point to a rise. OFS stock is expected to peak at $10.65 on Apr 20, 2026 before potentially ...
Vale S.A. (VALE) has recently captured investor attention with Barclays assigning an Equal-Weight rating to the stock o. The change in outlook reflects the current valuation of the stock at $17.82, ...
Jonathan Wolleben is an analyst from Citizens specializing in the Healthcare sector. Ranked #1705 out of 4631 analysts, they have issued 57 stock ratings with a success rate of 71.78% and an average ...
Our proprietary market analysis suggests predictions for Seer 's price over the next three months point to a rise. SEER stock is expected to peak at $17.43 on Jul 20, 2026 after potentially dipping to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results